| Views | |
|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 222 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 4 | 7 | 5 | 13 | 0 | 2 | 0 |
| Views | |
|---|---|
| 2021_Yu_etal.pdf | 103 |
